← Back to headlines
Novo Nordisk Considers Bangladesh as Insulin Production Hub
Pharmaceutical company Novo Nordisk is exploring the possibility of establishing Bangladesh as a central hub for insulin production.
26 Jun, 00:05 — 26 Jun, 00:05
Sources
Showing 1 of 1 sources



